No evidence that GATA3 rs570613 SNP modifies breast cancer risk
- 11 December 2008
- journal article
- research article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 117 (2), 371-379
- https://doi.org/10.1007/s10549-008-0257-1
Abstract
GATA-binding protein 3 (GATA3) is a transcription factor that is crucial to mammary gland morphogenesis and differentiation of progenitor cells, and has been suggested to have a tumor suppressor function. The rs570613 single nucleotide polymorphism (SNP) in intron 4 of GATA3 was previously found to be associated with a reduction in breast cancer risk in the Cancer Genetic Markers of Susceptibility project and in pooled analysis of two case-control studies from Norway and Poland (P trend = 0.004), with some evidence for a stronger association with estrogen receptor (ER) negative tumours [Garcia-Closas M et al. (2007) Cancer Epidemiol Biomarkers Prev 16:2269–2275]. We genotyped GATA3 rs570613 in 6,388 cases and 4,995 controls from the Breast Cancer Association Consortium (BCAC) and 5,617 BRCA1 and BRCA2 carriers from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA). We found no association between this SNP and breast cancer risk in BCAC cases overall (ORper-allele = 1.00, 95% CI 0.94–1.05), in ER negative BCAC cases (ORper-allele = 1.02, 95% CI 0.91–1.13), in BRCA1 mutation carriers RRper-allele = 0.99, 95% CI 0.90–1.09) or BRCA2 mutation carriers (RRper-allele = 0.93, 95% CI 0.80–1.07). We conclude that there is no evidence that either GATA3 rs570613, or any variant in strong linkage disequilibrium with it, is associated with breast cancer risk in women.Keywords
This publication has 21 references indexed in Scilit:
- Heterogeneity of Breast Cancer Associations with Five Susceptibility Loci by Clinical and Pathological CharacteristicsPLoS Genetics, 2008
- GATA-3 and the regulation of the mammary luminal cell fateCurrent Opinion in Cell Biology, 2008
- Common Breast Cancer-Predisposition Alleles Are Associated with Breast Cancer Risk in BRCA1 and BRCA2 Mutation CarriersAmerican Journal of Human Genetics, 2008
- Common Genetic Variation in GATA-Binding Protein 3 and Differential Susceptibility to Breast Cancer by Estrogen Receptor α Tumor StatusCancer Epidemiology, Biomarkers & Prevention, 2007
- GATA-3 Maintains the Differentiation of the Luminal Cell Fate in the Mammary GlandCell, 2006
- Commonly Studied Single-Nucleotide Polymorphisms and Breast Cancer: Results From the Breast Cancer Association ConsortiumJNCI Journal of the National Cancer Institute, 2006
- Breast cancer classification and prognosis based on gene expression profiles from a population-based studyProceedings of the National Academy of Sciences, 2003
- Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implicationsProceedings of the National Academy of Sciences, 2001
- The Robust Inference for the Cox Proportional Hazards ModelJournal of the American Statistical Association, 1989
- The Robust Inference for the Cox Proportional Hazards ModelJournal of the American Statistical Association, 1989